Trials / Unknown
UnknownNCT02334579
Stereotactic Body Radiotherapy for Stage I-III Prostate Cancer
Function-Preserving Stereotactic Body Radiotherapy for Clinical State I-III Prostate Cancer
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 146 (estimated)
- Sponsor
- Swedish Medical Center · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to find out the effects (good and bad) of highly focused radiation on you and your prostate cancer. The purpose of this evaluation is to see if this treatment causes fewer side effects that other standard treatment approaches, and to evaluate the effect of this treatment on your prostate tumor and your quality of life over time.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| RADIATION | CyberKnife Stereotactic Radiosurgery | Five treatments given over about one week. |
Timeline
- Start date
- 2014-12-01
- Primary completion
- 2023-12-01
- Completion
- 2024-12-01
- First posted
- 2015-01-08
- Last updated
- 2019-07-12
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT02334579. Inclusion in this directory is not an endorsement.